Stockreport

Whitehawk Therapeutics Presents Comprehensive Preclinical Data Highlighting its Next-Generation ADC Portfolio at the AACR 2026 [TheStreet.com]

Whitehawk Therapeutics, Inc.  (WHWK) 
PDF PR Newswire MORRISTOWN, N.J., April 19, 2026 Data demonstrate preclinical proof-of-concept for HWK-007, HWK-016 and HWK-206, underpinned by Whitehawk's proprietary [Read more]